In The News

  • Email
  • Print
  • Share
  • Text
Highlight Glossary Terms

  • Dr. Edward J. Benz, Jr., was part of a panel discussion that followed the preview screening of the film, “Cancer: The Emperor of All Maladies,” which features Dr. Stephen Sallan and Dr. David Nathan, as well as segments focused on Dr. Sidney Farber and the Jimmy Fund.

Tags: PatientEducation, PatientSupport

  • Dr. Ann Partridge helped launch a new app, called ResearchKit, part of Apple's mobile health program.  The app will allow researchers to access data from breast cancer survivors to provide improved post-treatment quality of life.

Tags: BreastCancer

  • Dr. Joseph Antin commented on the rising number of patients seeking bone marrow transplants and the demand it has created on registries that match patient needs with willing donors.

Tags: Leukemia, CopingWithCancer

  • Dr. Kimberly Stegmaier contributed to an editorial urging Congress to fund precision medicine research.

  • Dr. Stacy Gray and Dr. Katherine Janeway studied websites offering products or services related to "personalized cancer medicine." Their research showed online marketing to consumers often failed to explain the limits of the genetic tests.

Tags: Genomics, Genetics

  • Dr. Harold Burstein commented on a new study that found among women with operable hormone-receptor-negative breast cancer, who were given goserelin (Zoladex) in addition to chemotherapy, had lower rates of ovarian failure and higher rates of pregnancy compared with patients treated with chemotherapy alone.

Tags: BreastCancer

  • Dr. Craig Bunnell discussed Dana-Farber’s new plan to implement next day appointments with an oncologist for newly diagnosed patients.

Tags: PatientSupport, YawkeyCenter

  • Drs. Susan Block, Atul Gawande and Rachelle Bernacki were mentioned for the randomized study performed at Dana-Farber examining how closely the wishes of a group of the sickest patients are honored during end-of-life care.

Tags: EndOfLife

  • Dr. Anthony Letai led a study showing a new technique that can predict which specific drug will be most effective in treating various types of cancer tumors.

Tags: BasicResearch

  • Dr. Paul Richardson commented on the US Food and Drug Administration’s decision to expand the existing indication for lenalidomide (Revlimid) in combination with dexamethasone to include patients with newly diagnosed multiple myeloma.

Tags: MultipleMyeloma

Showing 31-40 of 550 items